Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
3.190
-0.050 (-1.54%)
At close: Jul 25, 2025, 4:00 PM
3.200
+0.010 (0.31%)
After-hours: Jul 25, 2025, 7:56 PM EDT

Anebulo Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
1317160121159-
Market Cap Growth
-28.24%17.53%-50.38%-23.75%--
Enterprise Value
1186646105159-
Last Close Price
3.192.732.355.206.82-
PB Ratio
9.7418.575.688.067.44-
P/TBV Ratio
9.7418.575.688.067.44-
Debt / Equity Ratio
-----0.07
Quick Ratio
24.3211.8710.5228.3982.7113.53
Current Ratio
25.2913.4610.9230.4089.6113.53
Return on Equity (ROE)
-83.37%-113.80%-91.42%-37.42%-249.85%-
Return on Assets (ROA)
-51.44%-65.97%-54.05%-22.93%-18.30%-
Return on Capital (ROIC)
-55.79%-72.06%-57.38%-23.41%-18.50%-
Earnings Yield
-5.87%-11.58%-19.48%-5.62%-19.00%-
Buyback Yield / Dilution
-16.67%-2.98%-7.41%-71.49%-13.44%-
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q